HHS Suddenly Dismantles CLIAC After 33 Years
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
FDA-nir
Subscribe today for access to
Articles and Reports
FDA Watch: CDRH Budget May Not See Steep Cuts in FY 2026
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
Next Steps: With LDT Final Rule Now Null, Industry Groups Urge Lab Managers and Pathologists to Advocate for Change
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
CMS Releases New CLIA-Waived Tests, Billing Codes
...
Already a member? Log in here
EBOLA Continues to Warrant Attention From Labs
...
Already a member? Log in here
ACLA Issues White Paper Arguing Against FDA Regulation of LDT
...
Already a member? Log in here
- « Previous
- 1
- …
- 15
- 16
- 17